Oral bisphosphonates in treatment of transient osteoporosis

Author： Kibbi L.   Touma Z.   Khoury N.   Arayssi T.  

Publisher： Springer Publishing Company

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.27, Iss.4, 2008-04, pp. : 529-532

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Osteoporosis in Men with Fluoride Alone or in Combination with Bisphosphonates

By Ringe J.D.   Rovati L.C.  

Calcified Tissue International, Vol. 69, Iss. 4, 2001-10 ,pp. : 252-255

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Pharmacology of Potent New Bisphosphonates for Postmenopausal Osteoporosis

By Chapurlat Roland D.  

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Optimizing Administration of Bisphosphonates in Women with Postmenopausal Osteoporosis

By Rackoff Paula J.   Sebba Anthony  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 245-251

Adis International

Access to resources Recommend Favorite

Combining Bisphosphonates with Hormone Therapy for Postmenopausal Osteoporosis

By Fadanelli Margaret E.  

Treatments in Endocrinology, Vol. 3, Iss. 6, 2004-01 ,pp. : 361-369

Adis International

Access to resources Recommend Favorite

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

By Ringe Johann   Farahmand Parvis  

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 474-484

Springer Publishing Company

Access to resources Recommend Favorite